Lunai Bioworks Inc.: 10-Q filed 2024-02-14

Name: Lunai Bioworks Inc.: 10-Q filed 2024-02-14
Creator: Lunai Bioworks Inc.

What Lunai Bioworks Inc. reported in its quarterly report filed 2024-02-14 (fiscal Q2 2024): 42 published measures, 123 facts as tagged in accession 0001731122-24-000248.

This filing

Form: 10-Q (quarterly report)
Filed: 2024-02-14
Fiscal period: fiscal Q2 2024
Accession: 0001731122-24-000248 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Lunai Bioworks Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2023-12-31	58,018,120	USD
At 2023-06-30	58,300,796	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2023-12-31	14,422,584	USD
At 2023-06-30	11,798,685	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2023-12-31	43,595,536	USD
At 2023-09-30	46,746,312	USD
At 2023-06-30	46,502,111	USD
At 2022-12-31	66,899,356	USD
At 2022-09-30	70,324,842	USD
At 2022-06-30	72,618,848	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2023-12-31	243,980	USD
At 2023-06-30	1,874,480	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-4,529,121	USD	92
2023-07-01 to 2023-12-31	-13,704,149	USD	184
2023-07-01 to 2023-09-30	-9,175,028	USD	92
2022-10-01 to 2022-12-31	-4,457,748	USD	92
2022-07-01 to 2022-12-31	-12,157,508	USD	184
2022-07-01 to 2022-09-30	-7,699,760	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2023-07-01 to 2023-12-31	-5,923,830	USD	184
2022-07-01 to 2022-12-31	-6,205,145	USD	184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2023-07-01 to 2023-12-31	41,584	USD	184
2022-07-01 to 2022-12-31	23,633	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-07-01 to 2023-12-31	5,409,682	USD	184
2022-07-01 to 2022-12-31	1,158,375	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2023-07-01 to 2023-12-31	-1,115,209	USD	184
2022-07-01 to 2022-12-31	-23,633	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2023-12-31	-257,733,402	USD
At 2023-06-30	-244,029,253	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	65,852,497	shares	92
2023-07-01 to 2023-12-31	65,166,625	shares	184
2022-10-01 to 2022-12-31	55,509,239	shares	92
2022-07-01 to 2022-12-31	55,304,356	shares	184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	65,852,497	shares	92
2023-07-01 to 2023-12-31	65,166,625	shares	184
2022-10-01 to 2022-12-31	55,509,239	shares	92
2022-07-01 to 2022-12-31	55,304,356	shares	184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-0.07	USD/shares	92
2023-07-01 to 2023-12-31	-0.21	USD/shares	184
2022-10-01 to 2022-12-31	-0.08	USD/shares	92
2022-07-01 to 2022-12-31	-0.22	USD/shares	184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-0.07	USD/shares	92
2023-07-01 to 2023-12-31	-0.21	USD/shares	184
2022-10-01 to 2022-12-31	-0.08	USD/shares	92
2022-07-01 to 2022-12-31	-0.22	USD/shares	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2023-12-31	496,896	USD
At 2023-06-30	508,989	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	999,228	USD	92
2023-07-01 to 2023-09-30	983,829	USD	92
2022-10-01 to 2022-12-31	819,955	USD	92
2022-07-01 to 2022-09-30	1,026,008	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-4,270,075	USD	92
2023-07-01 to 2023-12-31	-13,154,189	USD	184
2022-10-01 to 2022-12-31	-4,367,866	USD	92
2022-07-01 to 2022-12-31	-11,558,482	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2023-12-31	2,403,150	USD
At 2023-06-30	2,565,405	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2023-12-31	13,758,366	USD
At 2023-06-30	11,023,098	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2023-12-31	11,640,000	USD
At 2023-06-30	11,640,000	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2023-12-31	32,641	USD
At 2023-06-30	39,676	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	4,270,075	USD	92
2023-07-01 to 2023-12-31	13,154,189	USD	184
2022-10-01 to 2022-12-31	4,367,866	USD	92
2022-07-01 to 2022-12-31	11,558,482	USD	184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	620,521	USD	92
2023-07-01 to 2023-12-31	1,187,165	USD	184
2022-10-01 to 2022-12-31	325,959	USD	92
2022-07-01 to 2022-12-31	2,931,334	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2023-12-31	67,224,089	shares
At 2023-06-30	63,698,144	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2023-12-31	243,980	USD
At 2023-06-30	1,874,480	USD
At 2022-12-31	4,118,896	USD
At 2022-06-30	9,172,142	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2023-12-31	301,349,389	USD
At 2023-06-30	290,554,875	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2023-12-31	-27,231	USD
At 2023-06-30	-29,882	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2023-12-31	812,691	USD
At 2023-06-30	913,985	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2023-12-31	1,015,372	USD
At 2023-06-30	973,788	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2023-12-31	518,476	USD
At 2023-06-30	464,799	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2023-12-31	55,118,074	USD
At 2023-06-30	55,226,402	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2023-12-31	783,601	USD
At 2023-06-30	723,173	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-4,491,869	USD	92
2023-07-01 to 2023-12-31	-13,701,498	USD	184
2022-10-01 to 2022-12-31	-4,449,833	USD	92
2022-07-01 to 2022-12-31	-12,157,347	USD	184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	3,616,392	USD	92
2023-07-01 to 2023-12-31	11,906,602	USD	184
2022-10-01 to 2022-12-31	4,013,063	USD	92
2022-07-01 to 2022-12-31	8,569,903	USD	184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	27,198	USD	92
2023-07-01 to 2023-12-31	53,677	USD	184
2022-10-01 to 2022-12-31	27,338	USD	92
2022-07-01 to 2022-12-31	54,253	USD	184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	33,162	USD	92
2023-07-01 to 2023-12-31	60,422	USD	184
2022-10-01 to 2022-12-31	28,844	USD	92
2022-07-01 to 2022-12-31	57,245	USD	184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	5,964	USD	92
2023-07-01 to 2023-12-31	6,745	USD	184
2022-10-01 to 2022-12-31	1,507	USD	92
2022-07-01 to 2022-12-31	2,993	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-259,046	USD	92
2023-07-01 to 2023-12-31	-549,960	USD	184
2022-10-01 to 2022-12-31	-89,882	USD	92
2022-07-01 to 2022-12-31	-599,026	USD	184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2023-07-01 to 2023-12-31	5,256	USD	184
2022-07-01 to 2022-12-31	30,332	USD	184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2022-05-16 to 2022-05-17	299,178	USD	2

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	62,573	USD	92
2023-07-01 to 2023-12-31	123,796	USD	184
2022-10-01 to 2022-12-31	96,581	USD	92
2022-07-01 to 2022-12-31	241,042	USD	184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2023-07-01 to 2023-12-31	281,095	USD	184
2022-07-01 to 2022-12-31	3,153,358	USD	184

Inspect the source

Entity: Lunai Bioworks Inc. / CIK 0001527728
Captured: 2026-09-19T11:18:43.497Z
SEC response SHA-256: ac98dc0ce9d3f6a81ccca9ca1f946e5772f94eabe3529dac2d726fef17abed57

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001527728.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))